SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-21-000069
Filing Date
2021-11-04
Accepted
2021-11-04 16:16:11
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20210930.htm   iXBRL 10-Q 1522717
2 EX-31.1 anab-9302021x10qxexx311.htm EX-31.1 8542
3 EX-31.2 anab-9302021x10qxexx312.htm EX-31.2 8407
4 EX-32.1 anab-9302021x10qxexx321.htm EX-32.1 5072
5 EX-32.2 anab-9302021x10qxexx322.htm EX-32.2 4925
11 PIPELINE CHART anab-20210930_g1.jpg GRAPHIC 478405
  Complete submission text file 0001370053-21-000069.txt   7263126

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20210930.xsd EX-101.SCH 39837
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20210930_cal.xml EX-101.CAL 48551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20210930_def.xml EX-101.DEF 148147
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20210930_lab.xml EX-101.LAB 482235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20210930_pre.xml EX-101.PRE 288028
12 EXTRACTED XBRL INSTANCE DOCUMENT anab-20210930_htm.xml XML 1075283
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 211380176
SIC: 2834 Pharmaceutical Preparations